Sentynl Therapeutics, Inc. ("Sentynl"), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. ("Zydus"), announced today that the U.S. Food and Drug Administration (USFDA) ...

American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a ...

The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy ...

Common signs of autism include trouble with social communication and a fixation on certain routines or topics — Nelson says ...

At first, Ethel Branch thought her two-year-old son, Patro, had a cold or maybe the flu. Frantic, Branch rushed Patro to the ...

Hundreds came together to honor the life of a Bay Area mother and three-time double lung transplant recipient who was known ...

For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and ...

The neurodiversity movement has helped reframe autism not as a tragic diagnosis, but as a natural variation in human ...

To everyone deserving of a healthier future, For eighty years, the United Nations has guided global health efforts toward extending life expectancy. Today, however, the challenge is shifting. Globally ...

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDS ...

Heart disease is often considered to be a disease that adults have; however, congenital heart disease (CHD) is one of the ...